• Customer Login
  • Search
KindredBio
  • About
    • Background
    • Our Story
    • KindredBio Leadership
    • Board of Directors
  • Pipeline
    • Canine Pipeline
    • Clinical Trials
  • Products
    • Zimeta™ (dipyrone injection)
  • Technology
    • Veterinary Recombinant Biologics
    • Manufacturing Process
  • Education
    • Continuing Education
    • KINections
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Stock Information
    • Financial Information
    • Investor Resources
  • News
    • Press Releases
  • Contact Us
    • Contact Us
    • Careers
  • Menu

Archive for: PSD

You are here: Home / PSD

Single Portfolio: 2/3 Slider

Single Portfolio: 2/3 Gallery

KindredBio News

  • Elanco Announces Agreement to Acquire Kindred Biosciences
  • Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus
  • Event: Kindred Biosciences to Present at the LD Micro Invitational XI
  • Event: Kindred Biosciences to Present at the Stifel 2021 Virtual Jaws & Paws Conference
  • Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI

News Archives

  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • August 2015
  • May 2015
  • March 2015
  • December 2014
  • November 2014
  • August 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • December 2013
  • August 2013
  • July 2013
  • March 2013
  • February 2013
  • January 2013

News

  • Elanco Announces Agreement to Acquire Kindred BiosciencesJune 16, 2021 - 6:57 am
  • Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by ParvovirusJune 2, 2021 - 8:45 am
  • Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XIMay 25, 2021 - 8:57 am

Events

  • Event: Kindred Biosciences to Present at the LD Micro Invitational XIMay 25, 2021 - 9:14 am
  • Event: Kindred Biosciences to Present at the Stifel 2021 Virtual Jaws & Paws ConferenceMay 25, 2021 - 9:12 am
  • Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:48 am
$9.21 Stock is Up 2.87 (45.19%)
KIN (Common Stock)
Previous Close Volume
$6.34 31,918,900
Intraday High Intraday Low
$9.22 $9.16
52 Week High 52 Week Low
$7.45 $3.20
Exchange: NASDAQ CM
Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top